scispace - formally typeset
Journal ArticleDOI

Pharmaceutical Applications of Polymorphism

John K. Haleblian, +1 more
- 01 Aug 1969 - 
- Vol. 58, Iss: 8, pp 911-929
TLDR
Polymorphism is the ability of any element or compound to crystallize as more than one distinct crystal species (e.g., carbon as cubic diamond or hexagonal graphite).
About
This article is published in Journal of Pharmaceutical Sciences.The article was published on 1969-08-01. It has received 894 citations till now. The article focuses on the topics: Polymorphism (materials science) & Crystal.

read more

Citations
More filters
Journal ArticleDOI

Polymorphism, isostructurality and physicochemical properties of glibenclamide salts

TL;DR: In this article, aqueous solubility and hydration stability study of GBA-sodium, GBA ammonium, and glibenclamide-potassium (GBA-K) is reported.
Journal ArticleDOI

Preparation and Characterization of Polymorphs for an LTD4 Antagonist, RG 12525

TL;DR: This report describes the preparation and characterization of two polymorphic forms of RG 12525, a leukotriene D4 (LTD4) antagonist, with pure form I melting at 154 degrees C, 3 deg less than the melting temperature of form II.
Journal ArticleDOI

Investigation of physicochemical properties and in-vitro in-vivo evaluation of agomelatine polymorphs

TL;DR: In this paper, the variability of polymorphs of agomelatine was investigated and the in-vitro invivo correlation were established, and the presence of three polymorphs was corroborated through studies by XRPD, TGA and DSC.
Journal ArticleDOI

Solid-State NMR, X-ray Diffraction, and Thermoanalytical Studies Towards the Identification, Isolation, and Structural Characterization of Polymorphs in Natural Bile Acids

TL;DR: Combined solid-state NMR, powder, and single crystal X-ray diffraction, as well as thermoanalytical studies were performed towards the identification, isolation, and structural characterization of...
Patent

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

TL;DR: A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a
References
More filters
Journal ArticleDOI

Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices

TL;DR: The analyses suggest that for the latter system the time required to release 50% of the drug would normally be expected to be approximately 10 per cent of that required to dissolve the last trace of the solid drug phase in the center of the pellet.
Journal ArticleDOI

The united states pharmacopeia.

Robert A. Hatcher
- 04 Jan 1908 - 
TL;DR: The Pharmacopeia was called into being by physicians in 1820, and in 1850 pharmacists were admitted to the convention; since then physicians have gradually relinquished control to pharmacists, and to-day the authors are confronted with an anomalous condition.
Book

Thermal methods of analysis

TL;DR: In this article, a revised edition necessitated by the phenomenal growth of the field during the past decade contains 90% new material, focusing on tech niques and applications of thermal analysis.